Back to Search
Start Over
Modification of Cys residues in human thioredoxin-1 by p-benzoquinone causes inhibition of its catalytic activity and activation of the ASK1/p38-MAPK signalling pathway
- Source :
- Redox Biology, Vol 29, Iss, Pp-(2020), Shu, N, Hagglund, P, Cai, H, Hawkins, C L & Davies, M J 2020, ' Modification of Cys residues in human thioredoxin-1 by p-benzoquinone causes inhibition of its catalytic activity and activation of the ASK1/p38-MAPK signalling pathway ', Redox Biology, vol. 29, UNSP 101400 . https://doi.org/10.1016/j.redox.2019.101400, Redox Biology
- Publication Year :
- 2020
- Publisher :
- Elsevier, 2020.
-
Abstract
- Quinones can modify biological molecules through both redox-cycling reactions that yield radicals (semiquinone, superoxide and hydroxyl) and via covalent adduction to nucleophiles (e.g. thiols and amines). Kinetic data indicate that Cys residues in GSH and proteins are major targets. In the studies reported here, the interactions of a prototypic quinone compound, p-benzoquinone (BQ), with the key redox protein, thioredoxin-1 (Trx1) were examined. BQ binds covalently with isolated Trx1 forming quinoprotein adducts, resulting in a concentration-dependent loss of enzyme activity and crosslink formation. Mass spectrometry peptide mass mapping data indicate that BQ forms adducts with all of the Trx1 Cys residues. Glutathione (GSH) reacts competitively with BQ, and thereby modulates the loss of activity and crosslink formation. Exposure of macrophage-like (J774A.1) cells to BQ results in a dose-dependent loss of Trx and thioredoxin reductase (TrxR) activities, quinoprotein formation, and a decrease in GSH levels without a concomitant increase in oxidized glutathione. GSH depletion aggravates the loss of Trx and TrxR activity. These data are consistent with adduction of GSH to BQ being a primary protective pathway. Reaction of BQ with Trx in cells resulted in the activation of apoptosis signal-regulating kinase 1 (ASK1), and p38 mitogen-activated protein kinase (MAPK) leading to apoptotic cell death. These data suggest that BQ reacts covalently with Cys residues in Trx, including at the active site, leading to enzyme inactivation and protein cross-linking. Modification of the Cys residues in Trx also results in activation of the ASK1/p38-MAPK signalling pathway and promotion of apoptotic cell death.<br />Graphical abstract Image 1<br />Highlights • Quinone (e.g. p-benzoquinone, BQ) toxicity is linked to Michael adduction reactions. • Adduction of BQ to Cys residues in proteins are rapid (≤105 M−1 s−1) and selective. • BQ reaction with Cys inactivates thioredoxin (Trx) and yields quinone- and disulfide-linked dimers. • GSH reacts competitively with BQ and modulates damage, without GSSG formation. • BQ activates ASK1 and p38 pathways and induced apoptosis in cells via Trx damage.
- Subjects :
- 0301 basic medicine
Thioredoxin-Disulfide Reductase
Thioredoxin reductase
Clinical Biochemistry
Apoptosis
Biochemistry
p38 Mitogen-Activated Protein Kinases
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Thioredoxins
Michael addition
Benzoquinones
Humans
ASK1
Protein kinase A
Thioredoxin
lcsh:QH301-705.5
lcsh:R5-920
biology
Superoxide
Kinase
Organic Chemistry
Active site
Glutathione
Quinoprotein
030104 developmental biology
chemistry
lcsh:Biology (General)
biology.protein
Quinone
lcsh:Medicine (General)
Oxidation-Reduction
030217 neurology & neurosurgery
Research Paper
Signal Transduction
Subjects
Details
- Language :
- English
- ISSN :
- 22132317
- Volume :
- 29
- Database :
- OpenAIRE
- Journal :
- Redox Biology
- Accession number :
- edsair.doi.dedup.....2a269dad428f7af8469229aca36eda63